Tumor-specific Th17-polarized cells eradicate large established melanoma

CD4(+) T cells can differentiate into multiple effector subsets, but the potential roles of these subsets in anti-tumor immunity have not been fully explored. Seeking to study the impact of CD4(+) T cell polarization on tumor rejection in a model mimicking human disease, we generated a new MHC class...

詳細記述

保存先:
書誌詳細
主要な著者: Muranski, Pawel, Boni, Andrea, Antony, Paul A., Cassard, Lydie, Irvine, Kari R., Kaiser, Andrew, Paulos, Chrystal M., Palmer, Douglas C., Touloukian, Christopher E., Ptak, Krzysztof, Gattinoni, Luca, Wrzesinski, Claudia, Hinrichs, Christian S., Kerstann, Keith W., Feigenbaum, Lionel, Chan, Chi-Chao, Restifo, Nicholas P.
フォーマット: Artigo
言語:Inglês
出版事項: American Society of Hematology 2008
主題:
Immunobiology
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC2442746/
https://ncbi.nlm.nih.gov/pubmed/18354038
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2007-11-120998
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料